These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 30839208)

  • 1. Proteasome Activation as a New Therapeutic Approach To Target Proteotoxic Disorders.
    Njomen E; Tepe JJ
    J Med Chem; 2019 Jul; 62(14):6469-6481. PubMed ID: 30839208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting the 26S Proteasome To Protect Against Proteotoxic Diseases.
    Myeku N; Duff KE
    Trends Mol Med; 2018 Jan; 24(1):18-29. PubMed ID: 29233753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in Proteasome Enhancement by Small Molecules.
    George DE; Tepe JJ
    Biomolecules; 2021 Nov; 11(12):. PubMed ID: 34944433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small-Molecule Degraders beyond PROTACs-Challenges and Opportunities.
    Kastl JM; Davies G; Godsman E; Holdgate GA
    SLAS Discov; 2021 Apr; 26(4):524-533. PubMed ID: 33632029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteasome Activation to Combat Proteotoxicity.
    Jones CL; Tepe JJ
    Molecules; 2019 Aug; 24(15):. PubMed ID: 31387243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-Throughput Quantitative Assay Technologies for Accelerating the Discovery and Optimization of Targeted Protein Degradation Therapeutics.
    Simard JR; Lee L; Vieux E; Improgo R; Tieu T; Phillips AJ; Fisher SL; Pollock RM; Park E
    SLAS Discov; 2021 Apr; 26(4):503-517. PubMed ID: 33430712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methods for the discovery of small molecules to monitor and perturb the activity of the human proteasome.
    Maresh ME; Salazar-Chaparro AF; Trader DJ
    Future Med Chem; 2021 Jan; 13(2):99-116. PubMed ID: 33275045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small Molecule Modulation of Proteasome Assembly.
    Njomen E; Osmulski PA; Jones CL; Gaczynska M; Tepe JJ
    Biochemistry; 2018 Jul; 57(28):4214-4224. PubMed ID: 29897236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between the 20S proteasomes and prion-mediated neurodegenerations: potential therapeutic opportunities.
    Cecarini V; Bonfili L; Cuccioloni M; Mozzicafreddo M; Angeletti M; Eleuteri AM
    Apoptosis; 2010 Nov; 15(11):1322-35. PubMed ID: 20213200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trehalose Promotes Clearance of Proteotoxic Aggregation of Neurodegenerative Disease-Associated Aberrant Proteins.
    Kumar P; Kinger S; Dubey AR; Jagtap YA; Choudhary A; Prasad A; Jha HC; Dhiman R; Gutti RK; Mishra A
    Mol Neurobiol; 2024 Jul; 61(7):4055-4073. PubMed ID: 38057642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aim for the core: suitability of the ubiquitin-independent 20S proteasome as a drug target in neurodegeneration.
    Opoku-Nsiah KA; Gestwicki JE
    Transl Res; 2018 Aug; 198():48-57. PubMed ID: 30244692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted protein degradation and the enzymology of degraders.
    Fisher SL; Phillips AJ
    Curr Opin Chem Biol; 2018 Jun; 44():47-55. PubMed ID: 29885948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Itraconazole Confers Cytoprotection Against Neurodegenerative Disease-Associated Abnormal Protein Aggregation.
    Dubey AR; Mishra R; Jagtap YA; Kinger S; Kumar P; Dhiman R; Ghosh S; Singh S; Prasad A; Jana NR; Mishra A
    Mol Neurobiol; 2023 May; 60(5):2397-2412. PubMed ID: 36656458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expanding the role of proteasome homeostasis in Parkinson's disease: beyond protein breakdown.
    Bi M; Du X; Jiao Q; Chen X; Jiang H
    Cell Death Dis; 2021 Feb; 12(2):154. PubMed ID: 33542205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small Molecule Enhancement of 20S Proteasome Activity Targets Intrinsically Disordered Proteins.
    Jones CL; Njomen E; Sjögren B; Dexheimer TS; Tepe JJ
    ACS Chem Biol; 2017 Sep; 12(9):2240-2247. PubMed ID: 28719185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategies.
    Ciechanover A; Kwon YT
    Exp Mol Med; 2015 Mar; 47(3):e147. PubMed ID: 25766616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ubiquitin-dependent and independent roles of SUMO in proteostasis.
    Liebelt F; Vertegaal AC
    Am J Physiol Cell Physiol; 2016 Aug; 311(2):C284-96. PubMed ID: 27335169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Vital Role of Proteomics in Characterizing Novel Protein Degraders.
    Zhang AX; Cassidy K; Dahl G; Moreau K; Pachl F; Zuhl AM
    SLAS Discov; 2021 Apr; 26(4):518-523. PubMed ID: 33615886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular Protein Aggregates: Formation, Biological Effects, and Ways of Elimination.
    Wen JH; He XH; Feng ZS; Li DY; Tang JX; Liu HF
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37239937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteasome-mediated proteostasis: Novel medicinal and pharmacological strategies for diseases.
    Mishra R; Upadhyay A; Prajapati VK; Mishra A
    Med Res Rev; 2018 Sep; 38(6):1916-1973. PubMed ID: 29719055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.